|
1
|
Singal AK, Bataller R, Ahn J, Kamath PS
and Shah VH: ACG clinical guideline: Alcoholic liver disease. Am J
Gastroenterol. 113:175–194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beier JI and Mcclain CJ: Mechanisms and
cell signaling in alcoholic liver disease. Biol Chem.
391:1249–1264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Shea RS, Dasarathy S and Mccullough AJ:
Alcoholic liver disease. Hepatology. 51:227–229. 1995.
|
|
4
|
Szabo G: Gut-liver axis in alcoholic liver
disease. Gastroenterology. 148:30–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bode C and Bode JC: Effect of alcohol
consumption on the gut. Best Pract Res Clin Gastroenterol.
17:575–592. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lucey MR, Mathurin P and Morgan TR:
Alcoholic hepatitis. N Engl J Med. 360:2758–2769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malaguarnera G, Giordano M, Nunnari G,
Bertino G and Malaguarnera M: Gut microbiota in alcoholic liver
disease: Pathogenetic role and therapeutic perspectives. World J
Gastroenterol. 20:16639–16648. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Komatsuzaki N and Shima J: Effects of live
lactobacillus paracasei on plasma lipid concentration in rats fed
an ethanol-containing diet. Biosci Biotechnol Biochem. 76:232–237.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sung H, Kim SW, Hong M and Suk KT:
Microbiota-based treatments in alcoholic liver disease. World J
Gastroenterol. 22:6673–6682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
White JS, Hoper M, Parks RW, Clements WD
and Diamond T: Glutamine improves intestinal barrier function in
experimental biliary obstruction. Eur Surg Res. 37:342–347. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
dos Santos Rd, Viana ML, Generoso SV,
Arantes RE, Davisson Correia MI and Cardoso VN: Glutamine
supplementation decreases intestinal permeability and preserves gut
mucosa integrity in an experimental mouse model. JPEN J Parenter
Enteral Nutr. 34:408–413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li N, Lewis P, Samuelson D, Liboni K and
Neu J: Glutamine regulates Caco-2 cell tight junction proteins. Am
J Physiol Gastrointest Liver Physiol. 287:G726–G733. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li N and Neu J: Glutamine deprivation
alters intestinal tight junctions via a PI3-K/Akt mediated pathway
in Caco-2 cells. J Nutr. 139:710–714. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sellmann C, Baumann A, Brandt A, Jin CJ,
Nier A and Bergheim I: Oral supplementation of glutamine attenuates
the progression of nonalcoholic steatohepatitis in C57BL/6J mice. J
Nutr. 147:2041–2049. 2017.PubMed/NCBI
|
|
15
|
Huang H, Zeng Y, Lin H, Lin XY and Lin ZH:
Effects of fecal microbiota transplantation and joint application
of probiotics on rats with alcoholic liver disease. Int J Clin Exp
Med. 11:12368–12374. 2018.
|
|
16
|
Hartmann P, Chen WC and Schnabl B: The
intestinal microbiome and the leaky gut as therapeutic targets in
alcoholic liver disease. Front Physiol. 3:4022012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Addolorato G, Montalto M, Capristo E,
Certo M, Fedeli G, Gentiloni N, Stefanini GF and Gasbarrini G:
Influence of alcohol on gastrointestinal motility: Lactulose breath
hydrogen testing in orocecal transit time in chronic alcoholics,
social drinkers and teetotaler subjects. Hepatogastroenterology.
44:1076–1081. 1997.PubMed/NCBI
|
|
18
|
Wang L, Llorente C, Hartmann P, Yang AM,
Chen P and Schnabl B: Methods to determine intestinal permeability
and bacterial translocation during liver disease. J Immunol
Methods. 421:44–53. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lieber CS: Hepatic, metabolic and toxic
effects of ethanol: 1991 update. Alcohol Clin Exp Res. 15:573–592.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao B, Xu MJ, Bertola A, Wang H, Zhou Z
and Liangpunsakul S: Animal models of alcoholic liver disease:
Pathogenesis and clinical relevance. Gene Expr. 17:173–186. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian F, Chi F, Wang G, Liu X, Zhang Q,
Chen Y, Zhang H and Chen W: Lactobacillus rhamnosus CCFM1107
treatment ameliorates alcohol-induced liver injury in a mouse model
of chronic alcohol feeding. J Microbiol. 53:856–863. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Furuse M, Hirase T, Itoh M, Nagafuchi A,
Yonemura S and Tsukita S and Tsukita S: Occludin: A novel integral
membrane protein localizing at tight junctions. J Cell Biol.
123:1777–1788. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaudhry KK, Shukla PK, Mir H, Manda B,
Gangwar R, Yadav N, McMullen M, Nagy LE and Rao R: Glutamine
supplementation attenuates ethanol-induced disruption of apical
junctional complexes in colonic epithelium and ameliorates gut
barrier dysfunction and fatty liver in mice. J Nutr Biochem.
27:16–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Beek JH, de Moor MH, de Geus EJ, Lubke
GH, Vink JM, Willemsen G and Boomsma DI: The genetic architecture
of liver enzyme levels: GGT, ALT and AST. Behav Genet. 43:329–339.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ruan P, Gong ZJ and Zhang QR: Changes of
plasma D(−)-lactate, diamine oxidase and endotoxin in patients with
liver cirrhosis. Hepatobiliary Pancreat Dis Int. 3:58–61.
2004.PubMed/NCBI
|
|
26
|
Li H, Qiu P, Wang J, Niu C and Pan S:
Effects of compound Ginkgo biloba on intestinal permeability in
rats with alcohol-induced liver injury. Food Funct. 6:470–478.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mcclain C, Hill D, Schmidt J and Diehl AM:
Cytokines and alcoholic liver disease. Semin Liver Dis. 13:170–182.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ciećko-Michalska I, Szczepanek M, Cibor D,
Owczarek D, Skulina D, Szczepański W and Michalski M: Serum
cytokine concentration as prognostic factor in patients with
alcoholic liver disease. Przegl Lek. 63:249–252. 2006.(In Polish).
PubMed/NCBI
|
|
29
|
Gong ZY, Yuan ZQ, Dong ZW and Peng YZ:
Glutamine with probiotics attenuates intestinal inflammation and
oxidative stress in a rat burn injury model through altered iNOS
gene aberrant methylation. Am J Transl Res. 9:2535–2547.
2017.PubMed/NCBI
|
|
30
|
Hastings CN, Sheridan H, Pariante CM and
Mondelli V: Does diet matter? The use of polyunsaturated fatty
acids (PUFAs) and other dietary supplements in
inflammation-associated depression. Curr Top Behav Neurosci.
31:321–338. 2016. View Article : Google Scholar
|
|
31
|
Cresci GA: The gut microbiome: A new
frontier for alcohol investigation. Alcohol Clin Exp Res.
39:947–949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mutlu EA, Gillevet PM, Rangwala H,
Sikaroodi M, Naqvi A, Engen PA, Kwasny M, Lau CK and Keshavarzian
A: Colonic microbiome is altered in alcoholism. Am J Physiol
Gastrointest Liver Physiol. 302:G966–G978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bullotterson L, Feng W, Kirpich I, Wang Y,
Xiang Q, Liu Y, Gobejishvili L, Joshi-Barve S, Ayvaz T, Petrosino
J, et al: Metagenomic analyses of alcohol induced pathogenic
alterations in the intestinal microbiome and the effect of
lactobacillus rhamnosus GG treatment. PLoS One. 8:e530282013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bajaj JS, Ridlon JM, Hylemon PB, Thacker
LR, Heuman DM, Smith S, Sikaroodi M and Gillevet PM: Linkage of gut
microbiome with cognition in hepatic encephalopathy. Am J Physiol
Gastrointest Liver Physiol. 302:G168–G175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vassallo G, Mirijello A, Ferrulli A,
Antonelli M, Landolfi R, Gasbarrini A and Addolorato G: Review
article: Alcohol and gut microbiota-the possible role of gut
microbiota modulation in the treatment of alcoholic liver disease.
Aliment Pharmacol Ther. 41:917–927. 2015. View Article : Google Scholar : PubMed/NCBI
|
